Avacta establishes US commercial team
Avacta Group
49.50p
16:50 04/10/24
-1.39%
-0.70p
Affirmer biotherapeutic and reagent developer Avacta Group announced on Monday that it has established a commercial team of three people in the US, including the appointment of Dr Matthew Vincent as vice president therapeutics business development.
FTSE AIM All-Share
738.36
16:54 04/10/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,108.24
17:14 04/10/24
-1.30%
-291.15